Literature DB >> 19225019

Urinary proteome pattern in children with renal Fanconi syndrome.

Jens Drube1, Eric Schiffer, Harald Mischak, Markus J Kemper, Thomas Neuhaus, Lars Pape, Ralf Lichtinghagen, Jochen H H Ehrich.   

Abstract

BACKGROUND: The renal Fanconi syndrome (FS) is characterized by renal glucosuria, loss of electrolytes, bicarbonate and lactate, generalized hyperaminoaciduria and low-molecular-weight proteinuria. We studied the urinary low-molecular-weight proteome to identify excreted peptides indicative of a pathogenetic mechanism leading to tubular dysfunction.
METHODS: We established a urinary proteome pattern using capillary electrophoresis mass spectrometry (CE-MS) of 7 paediatric patients with cystinosis and 6 patients with ifosfamide-induced FS as the study group, and 54 healthy volunteers and 45 patients suffering from other renal diseases such as lupus nephritis (n = 8), focal segmental glomerulosclerosis (n = 27), minimal change disease (n = 7) and membranous glomerulonephritis (n = 3) as controls. Consequently, we conducted a blinded study consisting of 11 FS patients and 9 patients with renal disease other than FS. Additionally, we applied this pattern to 294 previously measured samples of patients with different renal diseases. Amino acid sequences of some marker proteins were obtained.
RESULTS: Specificity for detecting FS was 89% and sensitivity was 82%. The marker peptides constituting the proteome pattern are fragments derived from osteopontin, uromodulin and collagen alpha-1.
CONCLUSIONS: CE-MS can be used to diagnose FS in paediatric patients and might be a future tool for the non-invasive diagnosis of FS. The reduced amount of the marker proteins osteopontin and uromodulin indicates loss of function of tubular excretion in all patients suffering from FS regardless of the underlying cause. In addition, the six different fragments of the collagen alpha-1 (I) chain were either elevated or reduced in the urine. This indicates a change of proteases in collagen degradation as observed in interstitial fibrosis. These changes were prominent irrespectively of the stages of FS. This indicates fibrosis as an early starting pathogenetic reason for the development of renal insufficiency in FS patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19225019     DOI: 10.1093/ndt/gfp063

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  16 in total

1.  Fanconi-Bickel syndrome as an example of marked allelic heterogeneity.

Authors:  Mohammad Al-Haggar
Journal:  World J Nephrol       Date:  2012-06-06

Review 2.  Urinary proteomics as a novel tool for biomarker discovery in kidney diseases.

Authors:  Jing Wu; Yi-ding Chen; Wei Gu
Journal:  J Zhejiang Univ Sci B       Date:  2010-04       Impact factor: 3.066

Review 3.  Proteomic urinary biomarker approach in renal disease: from discovery to implementation.

Authors:  Joost P Schanstra; Harald Mischak
Journal:  Pediatr Nephrol       Date:  2014-03-15       Impact factor: 3.714

Review 4.  Novel techniques and newer markers for the evaluation of "proximal tubular dysfunction".

Authors:  Michael Ludwig; Sidharth K Sethi
Journal:  Int Urol Nephrol       Date:  2011-03-01       Impact factor: 2.370

5.  Proteomic candidate biomarkers of drug-induced nephrotoxicity in the rat.

Authors:  Rodney Rouse; Justyna Siwy; William Mullen; Harald Mischak; Jochen Metzger; Joseph Hanig
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

Review 6.  [Urinary proteomics: the diagnostic key for urinary tract abnormalities and kidney diseases in children?].

Authors:  J H H Ehrich; E Schiffer; J Drube
Journal:  Urologe A       Date:  2011-02       Impact factor: 0.639

Review 7.  Advances in urinary proteome analysis and biomarker discovery in pediatric renal disease.

Authors:  Cécile Caubet; Chrystelle Lacroix; Stéphane Decramer; Jens Drube; Jochen H H Ehrich; Harald Mischak; Jean-Loup Bascands; Joost P Schanstra
Journal:  Pediatr Nephrol       Date:  2009-07-15       Impact factor: 3.714

8.  Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria.

Authors:  Sten Andersen; Harald Mischak; Petra Zürbig; Hans-Henrik Parving; Peter Rossing
Journal:  BMC Nephrol       Date:  2010-11-01       Impact factor: 2.388

9.  Evaluation of the Zucker diabetic fatty (ZDF) rat as a model for human disease based on urinary peptidomic profiles.

Authors:  Justyna Siwy; Carlamaria Zoja; Julie Klein; Ariela Benigni; Wiliam Mullen; Bernd Mayer; Harald Mischak; Joachim Jankowski; Robert Stevens; Antonia Vlahou; Sophia Kossida; Paul Perco; Ferdinand H Bahlmann
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

Review 10.  Cystinosis: the evolution of a treatable disease.

Authors:  Galina Nesterova; William A Gahl
Journal:  Pediatr Nephrol       Date:  2012-08-18       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.